Samsung Electronics Co., Ltd.

The Green Cross Corporation

Medigenebio Corporation

Novmetapharma Co., Ltd.

Sri International

Korea University Research and Business Foundation

Samsung Display Co., Ltd.

Samsung Sdi Co., Inc.

Korea University Industrial Academic Collaboration Foundation

Yong-Chul Kim

Ho-suk Kang

Shang-hyeun Park

Yoon-chul Son

Tae-won Jeong

Thong-Gyu Jin

In-Taek Han

Jeong-na Heo

Jinwook Seo

Yong Woon Choi

Yo Kyung Chung

Sang Hoon Paik

Jong Mun Son

Yoo Chang Park

Il-Hwan Kim

Byeong-kwon Ju

Do-Yoon Kim

Hoe-Yune Jung

Heon-Jong Lee

Jong-Su Jeon

Yon-Su Kim

Seung-Hee Yang

Jong-Joo Moon

Hwan-Soo Yoo

Kyeong-Mi Choi

Deuk-seok Chung

Il-hwan Kim

Paul R Schwoebel

Chang-Soo Lee

Sun-il Kim

Chang-soo Lee

Ji-Yong Park

Dong-Yoon So

Tae-Gon Kim

Chan-Wook Baik

Min-jong Bae

Ha-jin Kim

Chan-sik Park

Tae-Won Jeong

Kyuhyun Lee

Yong-Wan Jin

Do-yoon Kim

Chan-Yul Park

Woo-Sung Cho

Seung-wook Kim

Han-Yeul Byun

Jin-Wook Seo

Byoung-Ju Lee

Torayuki Okuyama

In-Young Jang

Shang-Hyeun Park

A new use of a cyclo histidine-proline (Cyclo His-Pro, CHP) is disclosed. A composition including cyclo histidine-proline (CHP) as an active ingredient has an excellent protective effect to protect kidney and liver cells from damage and/or toxicity induced by various causes. The composition is useful and effective in protecting kidney and/or liver cells/tissues and in treating a subject with kidney and/or liver diseases and/or damages.

Cell-protecting composition containing cyclo histidine-proline as active ingredient

Composition for cell protection containing cyclo histidine-proline as active ingredient

The present invention provides, among other things, compositions and methods for CNS delivery of Idursulfase-beta, a human recombinant iduronate-2-sulfatase protein, for effective treatment of Hunter Syndrome. The compositions and methods provided by the present invention effectively reduce symptoms not only in brain and spinal cord but also in peripheral tissues including heart, liver, spleen, lung, and kidney.

Methods and compositions for treating hunter syndrome

The present disclosure relates to a cell-protecting pharmaceutical composition including a cyclo histidine-proline (Cyclo His-Pro, CHP) as an active ingredient. The cell-protecting pharmaceutical composition including the present cyclo histidine-proline (CHP) as an active ingredient has an excellent protective effect to protect kidney and liver cells from toxicity. Thus, the composition may be useful for the prevention or treatment of kidney and liver diseases.

According to an embodiment of the present disclosure, an electronic device may comprise a memory and a processor configured to produce compressed data by compressing data including a first block and a second block stored in the memory, wherein the processor may be configured to include a first replacement data table corresponding to first sub-data in the compressed data, the first sub-data included in the first block, and the first replacement data table produced based on, at least, rankings of first frequencies for the first sub-data, and include information for reference to the first replacement data table, corresponding to the second block, when second sub-data included in the second block and rankings of second frequencies for the second sub-data meet a designated condition with respect to the first sub-data included in the first block and the rankings of the first frequencies. Other embodiments are also possible.

Electronic device for compressing data and method for operating the same

A composition comprising recombinant iduronate-2-sulfatase (IDS) and a method for producing a purified recombinant IDS are provided. The glycosylation pattern and formylglycine content of the IDS composition are different from those of ELAPRASE&#xae; and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter Syndrome.

Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof

A composition comprising recombinant iduronate-2-sulfatase (IDS) and a method for producing a purified recombinant IDS are provided. The glycosylation pattern and formylglycine content of the IDS composition are different from those of ELAPRASE&#xae; and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter syndrome.

An x-ray generator includes a housing, a cathode block that is arranged in the housing and emits electrons via a field emission scheme, an anode block that is arranged in the housing and generates x-rays in response to the electrons emitted from the cathode block and collide with the anode block, and a heat sink block that contacts the cathode block and dissipates heat generated therein to an outside of the housing.

X-ray generator including heat sink block

An X-ray generator may comprise: an electron emission device comprising a plurality of electron emission units configured to emit electrons; an X-ray emission device configured to emit X-rays due to the electrons emitted from the electron emission device; and/or a parallel light extraction member configured to extract X-rays having directivity from among the X-rays emitted from the X-ray emission device and to allow the extracted X-rays having directivity to pass through the parallel light extraction member.

Flat panel type X-ray generators and X-ray imaging systems including the same

Disclosed are a composition comprising recombinant iduronate-2-sulfatase (IDS) and a method for treating Hunter syndrome. The glycosylation pattern and formylglycine content of the IDS composition are different from those of ELAPRASE&#xae; and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter syndrome.

An organic light emitting display panel may include a plurality of thin film transistors on a substrate, an insulating interlayer on the thin film transistors, a plurality of first electrodes on a portion of the insulating interlayer electrically connected to the thin film transistors, a plurality of metal lines on a portion of the insulating interlayer, a pixel defining layer on a portion of the insulating interlayer and a portion of the first electrodes, a plurality of organic light emitting structures on the first electrodes in the pixel area, a second electrode on the organic light emitting structures, and a spacer on the pixel defining layer. The insulation interlayer may partially expose electrodes of the thin film transistors. The pixel defining layer may define a pixel area by partially exposing the first electrodes, and an exposed area of the insulating interlayer by partially exposing the insulating interlayer.

Organic light emitting display panel including a protective spacer and method of manufacturing the same

Disclosed is a composition comprising recombinant iduronate-2-sulfatase (IDS). The glycosylation pattern and formylglycine content of the IDS composition are different from those of Elaprase and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter syndrome.

Provided are methods of aging an x-ray generator having carbon nanotube electron emitters. The method of aging an x-ray generator that includes a cathode, a gate electrode, and an anode, includes applying a desired, or alternatively predetermined anode voltage to the anode, and applying a direct current pulse voltage to the gate electrodes to emit electrons from electron emitters. The method further includes maintaining an anode current formed by electrons generated from the electron emitters constant.

Method of aging X-ray generator having carbon nanotube electron emitter

An electron emission device includes a cathode electrode; a mesh-shaped gate electrode spaced apart from the cathode electrode; a plurality of gate spacers between the cathode electrode and the gate electrode; and a plurality of electron emission sources between the cathode electrode and the gate electrode, and alternating with the plurality of gate spacers.

Electron emission device and X-ray generator including the same

An electron emission source includes nano-sized acicular materials and a cracked portion formed in at least one portion of the electron emission source. The acicular materials are exposed between inner walls of the cracked portion. A method for preparing the electron emission source, a field emission device including the electron emission source, and a composition for forming the electron emission source are also provided in the present invention.

Composition for forming electron emission source, electron emission source including the composition, method of preparing the electron emission source, and field emission device including the electron emission source

Growing community of inventors

Seoul, South Korea

Yong-Chul Kim